Wednesday, December 17

Healthcare

Ascendis raised to outperform by Oppenheimer ahead of drug launch

09/07/20241 Min Read

ahead Ascendis drug launch Oppenheimer outperform raised

Previous ArticleVor Bio stock rallies post-market on trem-cel study data

Next Article Lisata jumps on FDA orphan drug status for liver cancer drug